Menopause proteomics were consistently associated with inflammatory brain aging and Alzheimer’s dementia risk across nearly 15,000 women in a new study published in Nature Medicine.
|Podcasts|November 4, 2021
S3 E19: Alyssa Dweck, MD, on menopause products, her podcast, and more
Author(s)Lindsey Carr, Editor, Michael Krychman, MD
In this episode, Michael Krychman, MD, sat down with Alyssa Dweck, MD, gynecologist, and Bonafide medical advisor to catch up at this year's North American Menopause Society (NAMS) Annual Meeting.
Advertisement
More coverage from NAMS Annual Meeting can be
Advertisement
Related to this article
Seventy-one percent of women miss their first perimenopausal symptom because anxiety, brain fog, and mood changes precede hot flashes—and most attribute them to stress, per the Bonafide 2026 State of Menopause Survey.
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
A new Gallup survey found 51% of women in the United States reported negative healthcare experiences.
A new study links earlier menopause age to faster cognitive decline and earlier Alzheimer diagnosis.
The FDA office of Women's Health and Center for Drug Evaluation and Research and hosting a public workshop with a focus on testosterone use in menopausal women.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, weighs his own experience with pellet therapy against guideline evidence, then he and Maria Uloko, MD, close with candid advice for clinicians too afraid of hormones to start prescribing.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, and Maria Uloko, MD, walk through real-world dosing, cost workarounds, and the labs that actually matter for safety and efficacy.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Contemporary OB/GYN launches 'Missed & Dismissed' podcast to explore diagnostic gaps in women's health
2
Menopause proteomic scores associated with cognitive aging, dementia risk
3
CD38 is tied to age-related placental NAD+ decline in preclinical study
4
Zuranolone shows sustained PPD symptom improvement through day 90
5